Filtered news list testing
List of Reports
.pdf
05/22/2026 - Changes to the Composition of Guerbet's Board of Directors
.pdf
04/23/2026 - Q1 2026 revenue
.pdf
04/03/2026 - 2025 Universal Registration Document
.pdf
03/12/2026 - 2025 Full Year Results (Presentation)
.pdf
03/11/2026 - 2025 full-year results
.pdf
03/11/2026 - Change in Guerbet’s Board of Directors
.pdf
12/02/2025 - Adjustment of 2025 financial targets
.pdf
11/19/2025 - Blackout periods calendar 2026
Single report testing
.pdf
test report fabien V 09-07
Separator
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging